Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CELLEBRATE: Iltamiocel for Stress Urinary Incontinence
NCT01893138Phase 3Completed
- Sponsor
- Cook MyoSite
- Start
- Nov 2013
- Primary completion
- Nov 2019
- Modality
- Cell Therapies
- Countries
- 3
01
Overview
A Phase 3 trial of AMDC-USR in stress urinary incontinence (SUI), sponsored by Cook MyoSite. Started Nov 2013; status: completed.
02
Drugs
AMDC-USR
03
Conditions
stress urinary incontinence (SUI)
Beyond the preview
Go deeper on NCT01893138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01893138.